Clinical Trials Arena on MSN8d
Neurocrine Biosciences initiates trial of VMAT2 inhibitor in healthy adults
Neurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 ...
The Lancet16d
Retraction and republication—Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome
The Lancet has discovered that our editorial policies prior to the publication of the Clinical Picture Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with ...
The Lancet16d
Feeding dystonia, chorea, psychosis, and self-mutilation in an African patient with neuroacanthocytosis syndrome
A 34-year-old woman with a 2-year history of progressively worsening difficulties in walking, eating and swallowing, presented to our department. The patient's sister reported observing unusual ...